Mallinckrodt (MNK) StrataGraft Designated as Regenerative Medicine Advanced Therapy by U.S. FDA
Tweet Send to a Friend
Mallinckrodt plc (NYSE: MNK), today announced that StrataGraft® regenerative skin tissue is among the first products to be designated as ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
